Research Reports
LivaNova plc Invests nearly 13.9% of Total Revenue on R&D for Tricuspid Valve Regurgitation Finds Fact.MR
LivaNova plc Invests nearly 13.9% of Total Revenue on R&D for Tricuspid Valve Regurgitation Finds Fact.MR
Published by top news
Posted on July 9, 2021



